Novartis Offers Glivec for Free

Published: 2001-08-14 06:58:00

Updated: 2001-08-14 06:58:00

Novartis Korea has attracted considerable attention for their proposal to the Ministry of Health and Welfare to distribute free Glivec, a drug for treating chronic marrow type of leukemia to poor patients.

Novartis Korea's main point in their proposal 'Glivec Patient Support Program' involves...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK